Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 01 Mar 2023
In the MDA session track on amyotrophic lateral sclerosis, Stanley Appel, MD, provided his perspective on the condition, the most recent scientific developments that will benefit patients, and the direction that research and treatment in the area are taking.
Read Full NewsAI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, inconsistent or unavailable, a global survey...
The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.
Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.
The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.
A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.
Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.
As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.
1.
Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.
2.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
3.
A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Atezolizumab + Cabozantinib Postpones mCRPC Progression.
1.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
2.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
3.
Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology
4.
The Future of Oncology: Innovations Every Doctor Should Know
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge